v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Balance at Beginning at Dec. 31, 2023 $ 469,076 $ 16 $ 1,172,570 $ (76) $ (703,434)
Balance at Beginning (in Shares) at Dec. 31, 2023   158,832      
Issuance of common stock upon exercise of stock options 7,482   7,482    
Issuance of common stock upon exercise of stock options, shares   1,957      
Issuance of common stock under employee stock purchase plan 427   427    
Issuance of common stock under employee stock purchase plan, shares   52      
Issuance of common stock through at-the-market transactions net of offering costs 13,598   13,598    
Issuance of common stock through at-the-market transactions net of offering costs, shares   885      
Forfeiture of restricted stock subject to repurchase   (99)      
Vesting of restricted common stock, shares   88      
Vesting of common stock subject to repurchase 140   140    
Repurchase of unvested early exercised stock options   (5)      
Unrealized gain (loss) on marketable debt securities 138     138  
Stock-based compensation 39,990   39,990    
Net loss (243,787)       (243,787)
Balance at Ending at Dec. 31, 2024 287,064 $ 16 1,234,207 62 (947,221)
Balance at Ending (in Shares) at Dec. 31, 2024   161,710      
Forfeiture of unvested restricted common stock   (231)      
Issuance of common stock upon exercise of stock options 275   275    
Issuance of common stock upon exercise of stock options, shares   434      
Issuance of common stock through at-the-market transactions net of offering costs 19,653 $ 1 19,652    
Issuance of common stock through at-the-market transactions net of offering costs, shares   7,476      
Vesting of restricted common stock, shares   370      
Vesting of common stock subject to repurchase 155   155    
Unrealized gain (loss) on marketable debt securities (62)     $ (62)  
Stock-based compensation 29,876   29,876    
Issuance of common stock upon conversion of convertible debt 3,838   3,838    
Issuance of common stock upon conversion of convertible debt, shares   4,501      
Net loss (236,928)       (236,928)
Balance at Ending at Dec. 31, 2025 $ 103,871 $ 17 $ 1,288,003   $ (1,184,149)
Balance at Ending (in Shares) at Dec. 31, 2025   174,260